Evaluation of Photodynamic Therapy-Combined Intravitreal Bevacizumab in Age Related Macular Degeneration

Authors : Emine Pangal, Abdullah Özkırış

Pages : 8-13

Doi:10.55694/jamer.1385738

View : 61 | Download : 48

Publication Date : 2024-04-15

Article Type : Research

Abstract :Aim: It was aimed to compare treatment results of photodynamic therapy (PDT) and PDT-combined intravitreal bevacizumab injection (PDT+IVB) in patients with age-related macular degeneration (AMD). Materials and Methods: 63 eyes of 55 patients with neovascular AMD were included. Group 1 consisted of 40 eyes of 35, Group 2 consisted of 23 eyes of 20 patients. Visual acuity (VA), intraocular pressure measurement and fundus examination were performed. Pattern Electroretinography P50 amplitude and edema map values (EMV) were measured with Heidelberg Retina Tomograph (HRTII). Results: VA increased in 14 (35%), remained unchanged in 17 (42.5%), and decreased in 9 (22.5%) eyes in Group 1 (PDT). The PERG P50 amplitudes were compared with values of pre-treatment, and found to increased at 10.6%, 11.98%, and 8.46% and HRTII EMV were 5.86%, 4.88%, and 11.22% at 1st, 3rd, and 6th months, respectively. In Group 2 (PDT+IVB), VA improved in 9 (39.13%), remained unchanged in 8 (34.78%), and decreased in 6 (34.78%) eyes. PERG P50 amplitudes were reduced to 10.15%, 5.8%, and 0.1% and HRTII EMV were reduced to 13.07%, 12.17%, and 14.87% at 1st, 3rd, and 6th months, respectively. Conclusion: Verteporfin and PDT are effective and safe methods that preserve VA in subfoveal choroidal neovascular membranes due to neovascular AMD.
Keywords : Yaşa bağlı makula dejenerasyonu, fotodinamik tedavi, vasküler endotelyal büyüme faktörü, erken tanı, intravitreal enjeksiyon, bevacizumab